As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility.

Source: https://forextv.com/top-news/cytokinetics-announces-positive-results-from-sequoia-hcm-the-pivotal-phase-3-clinical-trial-of-aficamten-in-patients-with-obstructive-hypertrophic-cardiomyopathy/

Resistance training and L-arginine supplementation are determinant in genomic stability, cardiac contractility and muscle mass development in rats.

Source: https://www.healthcanal.com/life-style-fitness/best-vanilla-protein-powders